跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 69,489 条关于
“IDH1/2-mutated diffuse glioma”
全部
69,489
临床试验
46,047
药物
7,398
机构
1,401
资讯
14,643
去年
Vorasidenib Confirms Efficacy and Safety in IDH1/2-Mutant Diffuse Glioma
去年
FDA Grants First Accelerated Approval for H3 K27M-Mutated Diffuse Midline Glioma with Dordaviprone
10个月前
Vorasidenib Demonstrates Sustained Long-Term Efficacy in IDH-Mutant Grade 2 Glioma
去年
European Regulators Recommend Approval of Vorasidenib for IDH-Mutant Grade 2 Glioma
去年
Vorasidenib Approved in China's Boao Lecheng for IDH-Mutant Glioma Treatment
2年前
CAR T-cell Therapies Show Promise in Treating Diffuse Midline Glioma
2年前
FDA Approves Vorasidenib (Voranigo) for IDH-Mutant Grade 2 Glioma
去年
Olutasidenib Plus Azacitidine Shows Promise in IDH1-Mutated Relapsed/Refractory AML
去年
Real-World Data Confirm Ivosidenib Efficacy in IDH1-Mutated Cholangiocarcinoma
去年
Olutasidenib Maintenance Therapy Demonstrates Sustained Remission in IDH1-Mutated AML Patients
第 1 页，共 1465 页
上一页
下一页
